US Respiratory Disease Diagnostics Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US
Respiratory Disease Diagnostics Market Shares and Segment Forecasts
2017-2021: Emerging Opportunities and Growth Strategies for Suppliers”

report has been added to ResearchAndMarkets.com’s
offering

This new 283-page report presents detailed analysis of the US
Respiratory Diseases market, including sales forecasts and supplier
shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma,
Pneumonia, RSV and Tuberculosis. The report provides test volume and
sales projections for Hospitals, Physician Offices, Commercial, and
Public Health Labs.

In addition to market share and sales forecasts, the report:

  • Examines market applications of Molecular Diagnostics, Monoclonal
    Antibodies, Immunoassays, IT and other emerging technologies
  • Reviews features and operating characteristics of major analyzers used
    for microbiology testing
  • Profiles key suppliers and potential market entrants developing
    innovative
  • technologies and products
  • Analyzes emerging opportunities, alternative market penetration
    strategies, market entry barriers/risks, and strategic planning issues.

Key Topics Covered:

A. Major Infectious Disease Tests

1. Adenovirus

2. Influenza Viruses

3. Legionella

4. Mononucleosis

5. Mycoplasma

6. Pneumonia

7. Respiratory Syncytial Virus (RSV)

8. Tuberculosis

B. Instrumentation Review of Leading Analyzers Marketed by Abbott,
Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche,
Siemens, Tosoh, Wallac and Other Suppliers

C. Emerging Diagnostic Technologies

1. Molecular Diagnostics

2. Monoclonal Antibodies

3. Immunoassays

4. Differential Light Scattering

5. Information Technology

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

10. Diagnostic Imaging

11. Gel Microdroplets

12. Other

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix/Erba
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech/Leica
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

For more information about this report visit https://www.researchandmarkets.com/research/5hqwdf/us_respiratory?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Diagnostics,
Respiratory
Drugs